Consumer Research
Cybin Secures Up to US $500 Million via Convertible Debentures to Fuel Clinical Growth
LOS ANGELES- Cybin Inc. has entered into a securities purchase ...
Big Cannabis Companies Maintain Optimism in Florida Despite Adult‑Use Setback
LOS ANGELES- Major cannabis operators remain confident in the Florida ...
AYR Wellness Updates Delay of Q1 2025 Interim Filings
LOS ANGELES- AYR Wellness Inc. announced that it did not ...
Atai Life Sciences and Beckley Psytech Announce Strategic Merger to Form Atai Beckley
LOS ANGELES- Atai Life Sciences, a biopharmaceutical company, and Beckley Psytech, a private UK-based biotechnology firm, have announced a definitive agreement to merge, creating a new entity named Atai Beckley. The all-share transaction values Beckley ...
Comprehensive Cannabis Pangenome
LOS ANGELES- A collaborative study led by the Salk Institute for Biological Studies has constructed the most comprehensive genetic map of Cannabis sativa to date, analyzing 193 genomes from 144 biological samples. This pangenome reveals ...
Cresco Labs Reports $30 Million in Q1 Operating Cash Flow
LOS ANGELES- Cresco Labs Inc. reported $30 million in operating cash flow for the first quarter of 2025, reflecting its ongoing emphasis on cash generation and financial discipline. This figure follows a record $132 million ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
Cresco Labs Reschedules Q1 2025 Earnings
LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, ...
London Mayor Advocates for Decriminalization of Cannabis Possession
LOS ANGELES- London Mayor Sadiq Khan has endorsed recommendations from the London Drugs Commission (LDC) to decriminalize the possession of small quantities of natural cannabis for personal use. The LDC, established by Khan in 2022 ...
New Zealand Medicinal Cannabis Firms Propose Merger to Form Helius Health
LOS ANGELES- Three of New Zealand's medicinal cannabis companies—Helius Therapeutics, Green Leaf Group, and Elysian Group—have announced plans to merge into a single entity named Helius Health. The proposed consolidation aims to integrate the full ...
Verano Acquires Cannabist Company’s Assets in Virginia, Arizona for $105 Million
NEW YORK- Verano Holdings Corp., a Chicago-based cannabis operator, has reached an agreement to acquire the plant-touching operations of The Cannabist Co. in Arizona and Virginia. The acquisition, valued at $105 million in a mix ...
Kamala Harris Emerges as Pro-Cannabis Advocate Amidst Potential Presidential Bid
LOS ANGELES- Vice President Kamala Harris, once opposed to cannabis legalization during her tenure as District Attorney of San Francisco, has now become a leading advocate for the cause. In April, she made history as ...
Organigram Advances Cannabis Product Portfolio with $1M Investment in Phylos
LOS ANGELES- Organigram Holdings Inc. has announced the completion of a partial third tranche investment of $1 million into Phylos Bioscience Inc., a U.S.-based cannabis genetics company. This investment is part of a broader strategy ...
DeSantis Criticizes Cannabis Legalization Initiative’s Ballot Inclusion
LOS ANGELES- Florida Governor Ron DeSantis expressed concerns over the state's cannabis legalization initiative, known as Amendment 3, during a Florida Sheriffs' Association conference. DeSantis argued that the ballot summary for the amendment does not ...
SNDL Announces Major Restructuring, Job Cuts to Save $20 Million Annually
LOS ANGELES- Canadian cannabis company SNDL Inc. has announced a significant financial restructuring plan, which includes the elimination of 106 full-time positions. The restructuring aims to optimize corporate overhead spending and consolidate its cannabis segments ...
Minnesota Opens Social Equity License Application for Adult-Use Cannabis Market
LOS ANGELES- The Minnesota Office of Cannabis Management (OCM) has initiated the first social equity business license application process for the state's adult-use cannabis market. The application window, which began on Wednesday, will remain open ...
Tilray Brands’ Aphria RX GmbH Receives License Under Germany’s New Cannabis Law
LOS ANGELES- Tilray Brands, Inc. announced that its German subsidiary, Aphria RX GmbH, has received a cultivation license under Germany's newly enacted adult-use cannabis legalization law. The facility, previously licensed in 2019 for Germany's medical ...
Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot
LOS ANGELES- Dallas officials have finalized a petition allowing voters to decide on a cannabis decriminalization ordinance this November. The proposed measure aims to make the enforcement of Class A and Class B misdemeanor cannabis ...
Ohio Accelerates Adult-Use Cannabis Program Implementation
LOS ANGELES- The rulemaking process for Ohio's pending adult-use cannabis program is progressing rapidly, with sales expected to start by the third quarter of this year. Following voter approval of Issue 2, which legalized cannabis ...
Field Trip Health Ltd. Shares Rise 5.8% Amid Increased Trading Volume
LOS ANGELES- Field Trip Health Ltd. experienced a 5.8% increase in its share price during trading on Tuesday. The stock reached a high of C$1.11, before settling at C$1.09 by the end of the trading ...
Delaware Legalizes Cannabis: Recreational Sales Expected by Late 2024 or Early 2025
LOS ANGELES- Delaware recently legalized adult-use cannabis, but it may be up to two years before consumers can purchase it legally. According to Zoë Patchell, executive director of the Delaware Cannabis Advocacy Network, the state's ...
Study Highlights Psilocybin’s Significant Impact on Brain Function and Potential Therapeutic Uses
LOS ANGELES- A recent small randomized controlled trial has revealed that a single high dose of psilocybin induces significant and persistent changes in brain functional networks in healthy adults. The findings, published in Nature, provide ...
Medical Cannabis: Growth and Investment in 2024
LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments ...
FDA and FTC Target Delta-8 THC Edibles Resembling Popular Snacks
LOS ANGELES- The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) are taking action against companies selling delta-8 THC edibles packaged to resemble popular snacks, often marketed towards children. Delta-8 THC is ...
Numinus Wellness: Financial Challenges and Strategic Growth in Mental Health Care
LOS ANGELES- Numinus Wellness is at the forefront of transforming mental health care, focusing on innovative treatments, strategic mergers, and operational refinements. This article delves into the market trends, financial performance, and strategic initiatives shaping ...
Constellation Brands: Analysts Maintain Ratings
LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...
Canopy Growth Experiences Decline in Short Interest Amid Market Activity
LOS ANGELES- Canopy Growth Co. saw a significant decrease in short interest in June. As of June 30, short interest totaled 8,730,000 shares, a 20.7% decline from 11,010,000 shares on June 15. With an average ...
Snoop Dogg Launches First Licensed Cannabis Dispensary and Product Line
LOS ANGELES- Snoop Dogg has launched his first licensed cannabis dispensary, S.W.E.D., and an exclusive product line under the Death Row Cannabis brand. The shop, located near LAX airport in Los Angeles, opened on July ...
GOP-Led House Committee Approves Spending Bill Blocking Cannabis Rescheduling
LOS ANGELES- A key Republican-led House committee has approved a large-scale spending bill that would block the Justice Department from rescheduling cannabis. Additionally, the bill amends a longstanding rider protecting medical cannabis states from federal ...
Critics Slam Thai Government’s Approach to Cannabis
LOS ANGELES- Critics have strongly opposed the Thai government's plan to reclassify cannabis as a narcotic, arguing that it will harm businesses involved in cannabis-based products and undermine investor confidence in the country. On July ...
NHS Reimburses Cannabis for Chemotherapy-Induced Nausea and Vomiting
NEW YORK- The National Health Service (NHS) England has reimbursed a patient for the cost of medicinal cannabis flowers to manage chemotherapy-induced nausea and vomiting (CINV). Michael Roberts, diagnosed with rectosigmoid adenocarcinoma and lung metastases, ...
Constellation Brands: Analysts Maintain Ratings
LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands, maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal year 2025 ...
Canopy Growth Corporation Stock Performance and Upcoming Earnings Report
LOS ANGELES- In the latest market close, Canopy Growth Corporation (CGC) reached $6.50, marking a +0.31% increase compared to the previous day. This performance was below the S&P 500's daily gain of 0.55%. Meanwhile, the ...
Aurora Cannabis Submits Regular SEC Filing and Reports
LOS ANGELES- Aurora Cannabis Inc. a the medicinal chemicals and botanical products industry, has filed a Form 6-K report with the U.S. Securities and Exchange Commission (SEC) for July. The Edmonton, Alberta-based company submitted this ...
Medical Cannabis Industry Demonstrates Strong Economic Contributions and Market Trends
LOS ANGELES- The medical cannabis landscape continues to evolve, demonstrating significant economic contributions and offering vital insights into market trends. In 2024, data from licensed dispensaries and cultivation centers highlight robust retail and wholesale activities, ...
